Groups
RESEARCH GROUPS
País Vasco
Biosistemak - OSI Barrualde Galdakao
The start date cannot be later than the end date.
Risk factors for the development of in-hospital complications in pluripathological patients.
SARS-CoV-2 resistance analyses from the Phase 3 BIRCH study of obeldesivir in high-risk nonhospitalized participants with COVID-19.
Sex differences in HIV testing in Catalan emergency departments.
Strengthening antimicrobial resistance governance in Europe: a coordinated one health approach.
Strengthening non-communicable diseases monitoring systems in Europe through a multistakeholder collaborative approach: a key priority for advancing data-driven policymaking.
Telepharmacy follow-up using electronic patient-reported outcome measures in moderate-to-severe psoriasis.
Telepharmacy follow-up using electronic patient-reported outcome measures in moderate-to-severe psoriasis.
Ten-Year Outcomes in Colorectal Cancer-Competing Risks and Patient Vulnerability: A Prospective Multicenter Observational Study.
Use of physical restraint measures in the internal medicine department of an acute care hospital.
Ustekinumab and Janus Kinase Inhibitors Outperform Vedolizumab as Second-line Therapy in Anti-tumor Necrosis Factor-experienced Patients With Ulcerative Colitis.
Vaccination recommendations and adherence in inflammatory bowel disease: A physician-patient discordance study.
93 482 46 94
671 511 120
info@ricapps.es
